U.K. Dx zeroes in on bladder cancer biomarkers in urine odor

U.K. researchers say they've come up with a viable bladder cancer test that detects biomarkers for the disease through urine odor. While the test is in its early stages, it worked in preliminary testing on 98 male urine samples--24 from men with bladder cancer--with 96% accuracy. Their diagnostic device relies on the notion that cancer cells emit smelly gases filled with volatile organic compounds unique to the disease. While more testing on larger patient samples is needed, it could someday offer a less-invasive way to test for bladder cancer. More

Suggested Articles

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.

The former CEO of the molecular testing company Foundation Medicine, Troy Cox, has been named chairman of the Swiss big data firm Sophia Genetics.

Researchers at MIT used a machine-learning algorithm to uncover the potent antibiotic properties hiding within an old small-molecule candidate.